Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease

Clinical Colorectal Cancer - Tập 16 - Trang e205-e210 - 2017
Jordan Axelrad1, Anuja Kriplani2, Umut Ozbek3, Noam Harpaz2,4, Jean-Frederic Colombel5, Steven Itzkowitz5, Randall F. Holcombe2, Celina Ang2
1Division of Digestive and Liver Diseases, Department of Medicine, Columbia University Medical Center, New York, NY
2Division of Hematology and Oncology, Department of Medicine, the Icahn School of Medicine at Mount Sinai, New York, NY
3Population Health Science and Policy, the Icahn School of Medicine at Mount Sinai, New York, NY
4Department of Pathology, the Icahn School of Medicine at Mount Sinai, New York, NY
5Division of Gastroenterology, Department of Medicine, the Icahn School of Medicine at Mount Sinai, New York, NY

Tài liệu tham khảo

Molodecky, 2012, Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review, Gastroenterology, 142, 46, 10.1053/j.gastro.2011.10.001 Rutter, 2006, Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis, Gastroenterology, 130, 1030, 10.1053/j.gastro.2005.12.035 Eaden, 2001, The risk of colorectal cancer in ulcerative colitis: a meta-analysis, Gut, 48, 526, 10.1136/gut.48.4.526 Ullman, 2011, Intestinal inflammation and cancer, Gastroenterology, 140, 1807, 10.1053/j.gastro.2011.01.057 Ekbom, 1990, Ulcerative colitis and colorectal cancer. A population-based study, N Engl J Med, 323, 1228, 10.1056/NEJM199011013231802 Beaugerie, 2015, Cancers complicating inflammatory bowel disease, N Engl J Med, 372, 1441, 10.1056/NEJMra1403718 Axelrad, 2012, Effects of cancer treatment on inflammatory bowel disease remission and reactivation, Clin Gastroenterol Hepatol, 10, 1021, 10.1016/j.cgh.2012.06.016 Rajca, 2014, Impact of the diagnosis and treatment of cancer on the course of inflammatory bowel disease, J Crohns Colitis, 8, 819, 10.1016/j.crohns.2013.12.022 Tiersten, 1996, Influence of inflammatory bowel disease on the ability of patients to tolerate systemic fluorouracil-based chemotherapy, J Clin Oncol, 14, 2043, 10.1200/JCO.1996.14.7.2043 Naito, 2014, Feasibility of chemotherapy in patients with inflammatory bowel disease-related gastrointestinal cancer, Hepatogastroenterology, 61, 942 Goessling, 2006, Systemic treatment of patients who have colorectal cancer and inflammatory bowel disease, Gastroenterol Clin North Am, 35, 713, 10.1016/j.gtc.2006.07.006 Aarnio, 1998, Prognosis of colorectal cancer varies in different high-risk conditions, Ann Med, 30, 75, 10.3109/07853899808999387 van Heerden, 1980, Carcinoma of the colon and rectum complicating chronic ulcerative colitis, Dis Colon Rectum, 23, 155, 10.1007/BF02587618 Green, 1999, Rectal cancer and inflammatory bowel disease: natural history and implications for radiation therapy, Int J Radiat Oncol Biol Phys, 44, 835, 10.1016/S0360-3016(99)00091-7 Delaunoit, 2006, Colorectal cancer prognosis among patients with inflammatory bowel disease, Clin Gastroenterol Hepatol, 4, 335, 10.1016/j.cgh.2005.12.035 Sugita, 1993, Survival with colorectal cancer in ulcerative colitis. A study of 102 cases, Ann Surg, 218, 189, 10.1097/00000658-199308000-00011 Gyde, 1984, Survival of patients with colorectal cancer complicating ulcerative colitis, Gut, 25, 228, 10.1136/gut.25.3.228 Kiran, 2010, Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience, Ann Surg, 252, 330, 10.1097/SLA.0b013e3181e61e69 Ali, 2011, Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease, Clin Gastroenterol Hepatol, 9, 584, 10.1016/j.cgh.2011.04.016